Metastases disappeared in the first patient who received the oncobic vaccine. After four months of observation, no tumors were detected in him, said Alexander Gintsburg, the scientific director of the National Research Center for Epidemiology and Microbiology, in an interview with Gazeta.ru. Roe".
According to him, the patient continues to be monitored every month, and this will continue for three years.
Gunzburg also explained the principle of operation of an oncology vaccine created on the basis of mRNA technology: it adjusts the patient's immune system so that it itself destroys the malignant tumor and metastases. An individual medicine is created for each patient based on their genetic data.